Insiders Trades

★ Sign in to follow

RE

Richard E. Lowenthal

US·SEC (Form 4)

ARS Pharmaceuticals, Inc.

Insider activity · 24 months0 buys4 salesCumulative net flow

Nov 24 · 0 buys · 1 saleDec 24 · 0 buys · 2 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 1 saleSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

31

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (26 ops.)

€9.4M

Latest filing published 22 Aug 2025 for ARS Pharmaceuticals, Inc., €624k. Read the official filing

Filing timeline

BuySale

Richard E. Lowenthal

Insider track record

Disclosed buys

0

Disclosed sells

26

Signal history

Richard E. Lowenthal: trading record in brief

Richard E. Lowenthal is a declared insider of ARS Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 31 filings; the first trade dates from 8 November 2022 and the latest from 21 August 2025.

Every open-market trade on record is a sale: 26 sales worth €9.4M. Other entries cover 1 share grant and 3 option exercises. So far in 2025, the count stands at no purchases and 1 sale.

The newest entry dates from 22 August 2025: an open-market sale of €624k, in ARS Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Richard E. Lowenthal

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

ARS Pharmaceuticals, Inc. (US)

Declarations18 total

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives21 Aug 2025ARS Pharmaceuticals, Inc.

724,345 USD35SEC ↗

50,000 shares@ US$14.48696.5% of flowCommon StockSEC:0001415889-25-022761:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives17 Dec 2024ARS Pharmaceuticals, Inc.

583,575 USD38SEC ↗

50,000 shares@ US$11.67155.8% of flowCommon StockSEC:0001415889-24-029851:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives10 Dec 2024ARS Pharmaceuticals, Inc.

658,265 USD41SEC ↗

50,000 shares@ US$13.16536.5% of flowCommon StockSEC:0001415889-24-029011:0

◇

Richard E. Lowenthal

PRESIDENT AND CEOExecutives6 Dec 2024ARS Pharmaceuticals, Inc.

99,996 USD22SEC ↗

11,876 shares@ US$8.421.0% of flowCommon StockSEC:0001415889-24-028678:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives19 Nov 2024ARS Pharmaceuticals, Inc.

Same trade as the filing by Sarina Tanimoto, counted once · View ↗

697,510 USD38SEC ↗

50,000 shares@ US$13.95026.9% of flowCommon StockSEC:0001415889-24-027411:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives12 Nov 2024ARS Pharmaceuticals, Inc.

754,905 USD38SEC ↗

45,045 shares@ US$16.75897.4% of flowCommon StockSEC:0001415889-24-026866:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives15 Oct 2024ARS Pharmaceuticals, Inc.

Same trade as the filing by Sarina Tanimoto, counted once · View ↗

721,657 USD35SEC ↗

48,550 shares@ US$14.86426.9% of flowCommon StockSEC:0001415889-24-025368:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives8 Oct 2024ARS Pharmaceuticals, Inc.

Same trade as the filing by Sarina Tanimoto, counted once · View ↗

691,385 USD35SEC ↗

50,000 shares@ US$13.82776.6% of flowCommon StockSEC:0001415889-24-024980:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives17 Sept 2024ARS Pharmaceuticals, Inc.

Same trade as the filing by Sarina Tanimoto, counted once · View ↗

646,525 USD41SEC ↗

50,000 shares@ US$12.93056.0% of flowCommon StockSEC:0001415889-24-023709:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives10 Sept 2024ARS Pharmaceuticals, Inc.

Same trade as the filing by Sarina Tanimoto, counted once · View ↗

574,865 USD41SEC ↗

50,000 shares@ US$11.49735.4% of flowCommon StockSEC:0001415889-24-023290:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives20 Aug 2024ARS Pharmaceuticals, Inc.

Same trade as the filing by Sarina Tanimoto, counted once · View ↗

530,408 USD34SEC ↗

35,944 shares@ US$14.75655.0% of flowCommon StockSEC:0001415889-24-021877:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives13 Aug 2024ARS Pharmaceuticals, Inc.

171,908 USD34SEC ↗

14,599 shares@ US$11.77531.6% of flowCommon StockSEC:0001415889-24-021362:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives16 Jul 2024ARS Pharmaceuticals, Inc.

570,140 USD35SEC ↗

50,000 shares@ US$11.40285.4% of flowCommon StockSEC:0001415889-24-019770:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives9 Jul 2024ARS Pharmaceuticals, Inc.

480,885 USD34SEC ↗

50,000 shares@ US$9.61774.6% of flowCommon StockSEC:0001415889-24-019493:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives11 Jun 2024ARS Pharmaceuticals, Inc.

Same trade as the filing by Sarina Tanimoto, counted once · View ↗

19,498 USD34SEC ↗

2,166 shares@ US$9.0020.2% of flowCommon StockSEC:0001415889-24-016678:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives14 May 2024ARS Pharmaceuticals, Inc.

25,881 USD34SEC ↗

2,873 shares@ US$9.00840.2% of flowCommon StockSEC:0001415889-24-013387:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives7 May 2024ARS Pharmaceuticals, Inc.

467,135 USD34SEC ↗

50,000 shares@ US$9.34274.5% of flowCommon StockSEC:0001415889-24-012768:0

◇

Richard E. Lowenthal

PRESIDENT AND CEOExecutives23 Apr 2024ARS Pharmaceuticals, Inc.

69,496 USD22SEC ↗

82,733 shares@ US$0.840.7% of flowCommon StockSEC:0001415889-24-011469:0

◇

Richard E. Lowenthal

PRESIDENT AND CEOExecutives19 Apr 2024ARS Pharmaceuticals, Inc.

99,999 USD22SEC ↗

119,047 shares@ US$0.841.0% of flowCommon StockSEC:0001415889-24-011334:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives16 Apr 2024ARS Pharmaceuticals, Inc.

Same trade as the filing by Sarina Tanimoto, counted once · View ↗

464,020 USD34SEC ↗

50,000 shares@ US$9.28044.5% of flowCommon StockSEC:0001415889-24-011055:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives9 Apr 2024ARS Pharmaceuticals, Inc.

463,885 USD34SEC ↗

50,000 shares@ US$9.27774.4% of flowCommon StockSEC:0001415889-24-010659:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives22 Mar 2024ARS Pharmaceuticals, Inc.

Same trade as the filing by Sarina Tanimoto, counted once · View ↗

9,183 USD34SEC ↗

1,017 shares@ US$9.02980.1% of flowCommon StockSEC:0001415889-24-009154:0

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives22 Mar 2024ARS Pharmaceuticals, Inc.

Same trade as the filing by Sarina Tanimoto, counted once · View ↗

11,952 USD34SEC ↗

1,326 shares@ US$9.01320.1% of flowCommon StockSEC:0001415889-24-009154:1

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives25 Mar 2024ARS Pharmaceuticals, Inc.

Same trade as the filing by Sarina Tanimoto, counted once · View ↗

434,575 USD34SEC ↗

47,632 shares@ US$9.12364.2% of flowCommon StockSEC:0001415889-24-009154:3

▼

Richard E. Lowenthal

PRESIDENT AND CEOExecutives25 Mar 2024ARS Pharmaceuticals, Inc.

Same trade as the filing by Sarina Tanimoto, counted once · View ↗

434,612 USD34SEC ↗

47,635 shares@ US$9.12384.2% of flowCommon StockSEC:0001415889-24-009154:2

25 of 18 declarations